Non‐islet cell tumour induced hypoglycaemia with acromegaloid facial and aral swelling

The syndrome of non‐islet cell tumour hypoglycaemia (NICTH) has been linked with the synthesis and secretion of ‘big’ IGF‐II. We report a patient with a large pelvic clear cell sarcoma who developed recurrent severe hypoglycaemia and In addition presented with severe soft tissue facial swelling, skin tags and nuchal hyperpigmentation. After resection of the tumour serum ‘big’ IGF‐II returned to normal and the acromegaloid skin changes remitted.

[1]  S. Schwartz,et al.  Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients , 1994, Diabetes.

[2]  E. Froesch,et al.  Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? , 1992, The Journal of clinical investigation.

[3]  W. Daughaday,et al.  Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. , 1992, The Journal of clinical endocrinology and metabolism.

[4]  W. Burgess,et al.  The identification of O-glycosylated precursors of insulin-like growth factor II. , 1992, The Journal of biological chemistry.

[5]  R. Hintz.  Untoward events in patients treated with growth hormone in the USA. , 1992, Hormone research.

[6]  M. Durand,et al.  Transcutaneous Oxygen and Carbon Dioxide during the First Half Year of Life in Premature and Normal Term Infants , 1992, Pediatric Research.

[7]  W. Daughaday,et al.  Tumor secretion of growth factors. , 1991, Endocrinology and metabolism clinics of North America.

[8]  M. Uhlén,et al.  Characterization of an extended form of recombinant human insulin-like growth factor II. , 1991, The Journal of biological chemistry.

[9]  P. Sönksen,et al.  METABOLIC EFFECTS OF AN INSULIN‐LIKE FACTOR CAUSING HYPOGLYCAEMIA IN A PATIENT WITH A HAEMANGIOPERICYTOMA , 1990, Clinical endocrinology.

[10]  R. Baxter,et al.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Rotwein,et al.  Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. , 1988, The New England journal of medicine.

[12]  P. Zumstein,et al.  Amino acid sequence of a variant pro-form of insulin-like growth factor II. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Froesch,et al.  Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? , 1982, The Journal of clinical endocrinology and metabolism.

[14]  E. Froesch,et al.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. , 1981, The Journal of clinical investigation.

[15]  D. R. Miller,et al.  Hypoglycemia Due to Nonpancreatic Mesodermal Tumors: Report of Two Cases , 1959, Annals of surgery.